Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06196515

Anti-bacterial Potential of Nano Calcium Hydroxide as an Intracanal Medication

Evaluation of the Antibacterial Potential of Nano Calcium Hydroxide as an Intracanal Medication: A Randomized Clinical Trial

Status
Recruiting
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
54 (estimated)
Sponsor
British University In Egypt · Academic / Other
Sex
All
Age
21 Years – 49 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to evaluate the anti-bacterial potential of Nano Calcium Hydroxide as an intracanal medication in primary endodontic treatment of permanent molars.

Detailed description

This study is conducted to evaluate the bacterial reduction capability of hydrogel loaded with Nano Calcium Hydroxide and paste form of nano and conventional calcium hydroxide as an intracanal medication. The hydrogel will be synthesized in a new rapid in situ form that can turn from liquid into gel when reaching body temperature. The efficacy of bacterial reduction will be compared with Nano Calcium Hydroxide and conventional Calcium Hydroxide in paste form. The evaluation is to be done by quantitative microbiological assessment of samples which are gained from the root canal before and after intracanal medication placement in roots of permanent molars, having PAI score ≥ 2.

Conditions

Interventions

TypeNameDescription
DRUGCalcium hydroxideplacement of intracanal medication for the three groups will be done after cleaning and shaping of the root canals and it will be left for one week.
DRUGnano calcium hydroxideplacement of intracanal medication for the three groups will be done after cleaning and shaping of the root canals and it will be left for one week.

Timeline

Start date
2024-08-01
Primary completion
2025-09-01
Completion
2025-12-01
First posted
2024-01-09
Last updated
2024-08-19

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06196515. Inclusion in this directory is not an endorsement.